IGG4 RELATED DISEASE

Clinical trials for IGG4 RELATED DISEASE explained in plain language.

Never miss a new study

Get alerted when new IGG4 RELATED DISEASE trials appear

Sign up with your email to follow new studies for IGG4 RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 2 Not yet finished but already full! 2 Completed 3 Terminated 1

New drug hope for rare inflammatory disease falls short

Disease control Terminated

This study tested a drug called elotuzumab for people with active IgG4-related disease, a condition that causes swelling and damage in organs. The trial was split into two parts: first to check safety, then to compare elotuzumab plus steroids against a placebo plus steroids. Only…

Matched conditions: IGG4 RELATED DISEASE

Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Jun 09, 2026 12:06 UTC

IGG4 RELATED DISEASE

Get alerted when new IGG4 RELATED DISEASE trials appear

New drug hope for rare inflammatory disease falls short